This segment focuses on developing and commercializing hyaluronic acid (HA)-based therapies for the treatment of osteoarthritis pain. Key products include Monovisc, Orthovisc, Cingal, and Hyvisc, which are designed to provide pain relief and improve joint function. Research and development efforts are directed towards enhancing the efficacy and duration of these therapies, as well as exploring new formulations and delivery methods. Clinical trials are conducted to demonstrate the safety and effectiveness of these products, and regulatory approvals are sought to expand market access. The segment aims to address the unmet needs of patients suffering from OA by providing minimally invasive treatment options that can delay or avoid the need for joint replacement surgery. Future opportunities include expanding into new geographic markets and developing combination therapies that address multiple aspects of OA.

This segment is dedicated to developing and commercializing products that promote tissue regeneration and healing in orthopedic applications. The focus is on leveraging hyaluronic acid (HA) technology to create scaffolds and matrices that support cell growth and tissue repair. Research and development activities include exploring new biomaterials, cell-based therapies, and growth factors to enhance regenerative outcomes. Clinical trials are conducted to evaluate the safety and efficacy of these products in various orthopedic conditions, such as cartilage repair and bone regeneration. The segment aims to provide innovative solutions that can restore damaged tissues and improve patient outcomes. Future opportunities include expanding into new therapeutic areas, such as wound healing and sports medicine, and developing personalized regenerative therapies based on patient-specific factors.

This segment encompasses a portfolio of bone-preserving joint technology products and soft tissue repair solutions. Research and development efforts are focused on creating innovative implants, instruments, and biologics that can preserve and restore joint function. Technologies used include advanced materials, minimally invasive surgical techniques, and regenerative medicine approaches. The therapeutic areas covered include sports medicine, trauma, and joint reconstruction. The segment aims to provide surgeons with a comprehensive set of tools and technologies to address a wide range of orthopedic conditions. Future opportunities include expanding into new surgical specialties, such as spine and extremities, and developing robotic-assisted surgical solutions.